New blood test could replace invasive cancer biopsies

NCT ID NCT04490564

Completed Knowledge-focused Sponsor: Pharmassist Ltd Source: ClinicalTrials.gov ↗

First seen Jan 07, 2026 · Last updated Jun 12, 2026 · Updated 17 times

Summary

This study tested a new blood test (liquid biopsy) to find cancer markers in 135 people with head and neck, lung, or skin cancer. The goal was to see if the blood test works as well as a standard tissue biopsy. The study did not provide treatment but aimed to improve how doctors monitor cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Aretaieio University Hospital of Athens

Athens, Attica, 11528, Greece
Bioclinic

Thessaloniki, Thessaloniki, 546 22, Greece
Metropolital Hospital

Piraeus, Piraeus, 18547, Greece
Sotiria Thoracic Diseases Hospital of Athens

Athens, Attica, 11527, Greece
University General Hospital of Alexandroupoli

Alexandroupoli, Alexandroupolis, 68100, Greece
University General Hospital of Athens Attikon

Athens, Attica, 124 62, Greece

Conditions

Explore the condition pages connected to this study.

HEAD AND NECK SQUAMOUS CELL CARCINOMA HEAD AND NECK SQUAMOUS CELL CARCINOMA MELANOMA NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER